Morgan Stanley Put 300 AMGN 18.12.../ DE000MJ3Q4M6 /
2025-01-02 5:59:58 PM | Chg.+0.22 | Bid9:20:24 PM | Ask9:20:24 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
6.22EUR | +3.67% | 6.33 Bid Size: 50,000 |
6.51 Ask Size: 50,000 |
Amgen Inc | 300.00 USD | 2026-12-18 | Put |
GlobeNewswire
2024-08-29
Great Place To Work Announces the 2024 Best Workplaces in Asia Representing 6.9 Million Employee Exp...
GlobeNewswire
2024-08-28
Prevent Cancer Annual Gala to celebrate three decades of commitment to cancer prevention and early d...
GlobeNewswire
2024-08-15
Alvotech Reports Record Revenues and Adjusted EBITDA for the Second Quarter and First Six Months of ...
GlobeNewswire
2024-08-12
TScan Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
2024-08-08
CytomX Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
2024-08-08
Ardelyx Appoints Experienced Biopharma Executive, Eric Foster, as Chief Commercial Officer
GlobeNewswire
2024-08-05
Avalyn Appoints Erin Lavelle, Seasoned Biopharma Finance Executive, to its Board of Directors
GlobeNewswire
2024-08-01
CytomX Therapeutics to Report Second Quarter 2024 Financial Results on August 8, 2024